[go: up one dir, main page]

WO2018084061A1 - Procédé de traitement par membrane d'osmose inverse et système de traitement par membrane d'osmose inverse - Google Patents

Procédé de traitement par membrane d'osmose inverse et système de traitement par membrane d'osmose inverse Download PDF

Info

Publication number
WO2018084061A1
WO2018084061A1 PCT/JP2017/038675 JP2017038675W WO2018084061A1 WO 2018084061 A1 WO2018084061 A1 WO 2018084061A1 JP 2017038675 W JP2017038675 W JP 2017038675W WO 2018084061 A1 WO2018084061 A1 WO 2018084061A1
Authority
WO
WIPO (PCT)
Prior art keywords
reverse osmosis
osmosis membrane
water
treated
membrane treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2017/038675
Other languages
English (en)
Japanese (ja)
Inventor
賢吾 河原
吉川 浩
勇規 中村
明広 高田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organo Corp
Original Assignee
Organo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organo Corp filed Critical Organo Corp
Priority to CN201780067825.7A priority Critical patent/CN109890764A/zh
Priority to JP2018548965A priority patent/JP6622424B2/ja
Publication of WO2018084061A1 publication Critical patent/WO2018084061A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/02Reverse osmosis; Hyperfiltration ; Nanofiltration
    • B01D61/10Accessories; Auxiliary operations
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/02Reverse osmosis; Hyperfiltration ; Nanofiltration
    • B01D61/12Controlling or regulating
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/44Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis

Definitions

  • the present invention relates to a reverse osmosis membrane treatment method and a reverse osmosis membrane treatment system.
  • a reverse osmosis membrane In reverse osmosis membrane treatment using a reverse osmosis membrane (RO membrane), there is known a method in which various chlorine-based oxidants and bromine-based oxidants are present in the water to be treated of the reverse osmosis membrane for the purpose of slime suppression.
  • Known bromine-based oxidizing agents include a reaction product of an oxidizing agent such as hypochlorous acid and bromide ions, hypobromite, or a stabilized hypobromite composition.
  • Patent Literature 1 discloses a stabilized hypobromite composition containing a bromine-based oxidant or a reaction product of a bromine compound and a chlorine-based oxidant and a sulfamic acid compound, and a membrane separation provided with a separation membrane. A method is described which is present in the water supply or washing water to the apparatus.
  • Patent Document 1 in the reverse osmosis membrane treatment of freshwater treated water, when the low-pressure reverse osmosis membrane is operated at a primary side inlet pressure of 0.75 MPa, the permeated water retention rate is 80 if the pH is 5.5 or higher. It is described that the permeated water amount is not significantly reduced.
  • the operating pressure (primary side inlet pressure) of the reverse osmosis membrane is 0.75 MPa
  • the operating pressure (primary side inlet pressure) of the reverse osmosis membrane such as seawater desalination and wastewater recovery is high (for example, it has been found that when the operation is performed at 3 MPa or more, the amount of permeated water may decrease.
  • An object of the present invention is to have a reverse osmosis membrane slime-inhibiting effect in a high pressure reverse osmosis membrane treatment by passing treated water through a reverse osmosis membrane to obtain treated water and concentrated water. It is an object of the present invention to provide a reverse osmosis membrane treatment method and a reverse osmosis membrane treatment system that suppress the decrease.
  • the present invention is a reverse osmosis membrane treatment method for obtaining treated water and concentrated water by passing treated water through a reverse osmosis membrane, wherein a primary inlet pressure of the reverse osmosis membrane is 3 MPa or more, and the treated water
  • the stabilized hypochlorous acid composition containing a bromine-based oxidant and a sulfamic acid compound and a stabilized hypochlorous acid containing a chlorine-based oxidant and a sulfamic acid compound in the water to be treated
  • a reverse osmosis membrane treatment method in which at least one of acid compositions is present.
  • the present invention is also a reverse osmosis membrane treatment method for obtaining treated water and concentrated water by passing water to be treated through a reverse osmosis membrane, wherein the primary inlet pressure of the reverse osmosis membrane is 3 MPa or more, and The reverse osmosis membrane treatment method, wherein the pH of the treated water is 7 or more, and the stabilized hypobromite composition containing bromine and a sulfamic acid compound is present in the treated water.
  • the stabilized hypobromite composition and the stable water are added to the treated water so that the total chlorine concentration in the concentrated water is in the range of 0.05 mg / L or more and less than 10 mg / L. It is preferred to have at least one of the hypochlorous acid composition present.
  • the reverse osmosis membrane is preferably a high pressure membrane.
  • the present invention also provides a reverse osmosis membrane treatment system for obtaining treated water and concentrated water by passing treated water through a reverse osmosis membrane, wherein the pH of the treated water is 7 or more
  • a reverse osmosis membrane treatment apparatus a pressure means for pressurizing the water to be treated so that a primary inlet pressure of the reverse osmosis membrane is 3 MPa or more, and a bromine-based oxidizing agent and sulfamic acid in the water to be treated.
  • an addition means for adding at least one of a stabilized hypochlorous acid composition containing a compound and a stabilized hypochlorous acid composition containing a chlorine-based oxidant and a sulfamic acid compound. Processing system.
  • the present invention also provides a reverse osmosis membrane treatment system for obtaining treated water and concentrated water by passing treated water through a reverse osmosis membrane, wherein the pH of the treated water is 7 or more,
  • a reverse osmosis membrane treatment apparatus a pressure means for pressurizing the water to be treated so that a primary inlet pressure of the reverse osmosis membrane is 3 MPa or more, and bromine and a sulfamic acid compound in the water to be treated.
  • a means for adding a stabilized hypobromite composition for obtaining treated water and concentrated water by passing treated water through a reverse osmosis membrane, wherein the pH of the treated water is 7 or more
  • a reverse osmosis membrane treatment apparatus a pressure means for pressurizing the water to be treated so that a primary inlet pressure of the reverse osmosis membrane is 3 MPa or more, and bromine and a sulfamic acid compound in the water to be treated.
  • the adding means adds the stabilized hypochlorous acid to the treated water so that the total chlorine concentration in the concentrated water is in the range of 0.05 mg / L or more and less than 10 mg / L. At least one of a composition and the stabilized hypochlorous acid composition is added, and at least one of the stabilized hypochlorous acid composition and the stabilized hypochlorous acid composition is added. It is preferable to further include a total chlorine concentration measuring means for measuring the total chlorine concentration of the water to be treated or the concentrated water.
  • the reverse osmosis membrane is preferably a high pressure membrane.
  • water to be treated is passed through the reverse osmosis membrane to obtain treated water and concentrated water. Can be suppressed.
  • FIG. 1 An outline of an example of a reverse osmosis membrane treatment system according to an embodiment of the present invention is shown in FIG.
  • the reverse osmosis membrane treatment system 1 includes a reverse osmosis membrane treatment device 12 having a reverse osmosis membrane.
  • the reverse osmosis membrane treatment system 1 may include a treated water tank 10 that stores treated water.
  • a water pipe 18 to be treated is connected to the inlet of the water tank 10, and the outlet of the water tank 10 and the inlet of the reverse osmosis membrane treatment device 12 are connected via a pump 14.
  • the water to be treated is connected by a water supply pipe 20.
  • a permeated water pipe 22 is connected to the permeated water outlet of the reverse osmosis membrane treatment apparatus 12, and a concentrated water pipe 24 is connected to the concentrated water outlet.
  • a total chlorine concentration measuring device 16 is connected to the concentrated water pipe 24 as a total chlorine concentration measuring means.
  • An addition pipe 26 is connected to the water tank 10 as an addition means for adding at least one of a stabilized hypobromite composition and a stabilized hypochlorous acid composition that are slime inhibitors.
  • a pH measuring device 30 is installed as a pH measuring means for measuring the pH of the water to be treated.
  • a pH adjuster addition pipe 28 may be connected to the water tank 10 as pH adjusting means for adjusting the pH of the water to be treated so that the pH of the water to be treated becomes 7 or more.
  • the treated water is stored in the treated water tank 10 through the treated water pipe 18 as necessary.
  • At least one of the stabilized hypobromite composition and the stabilized hypochlorous acid composition (hereinafter sometimes simply referred to as “slime inhibitor”) is added to the treated water in the treated water tank 10. 26 (slime inhibitor addition step).
  • the pH adjusting agent is added to the pH adjusting agent addition pipe 28 so that the pH of the water to be treated is 7 or more when the pH of the water to be treated is less than 7.
  • the water to be treated is supplied to the reverse osmosis membrane treatment apparatus 12 through the water to be treated supply pipe 20.
  • the water to be treated is pressurized so that the primary inlet pressure of the reverse osmosis membrane becomes 3 MPa or more by the pump 14 as the pressurizing means, and the reverse osmosis membrane treatment of the water to be treated is performed.
  • the permeated water obtained by the reverse osmosis membrane treatment is discharged through the permeated water pipe 22, and the concentrated water is discharged through the concentrated water pipe 24.
  • the total chlorine concentration of the concentrated water is measured by the total chlorine concentration measuring device 16 (total chlorine concentration measuring step).
  • the slime inhibitor and the pH adjuster may be added to the water to be treated in the treated water pipe 18, or added to the water to be treated on the suction side and the discharge side of the pump 14 in the treated water supply pipe 20. Also good. Further, the pH measurement by the pH measuring device 30 may be performed in the treated water pipe 18 as long as it is a subsequent stage of the pH adjusting agent adding pipe 28, or the suction side of the pump 14 in the treated water supply pipe 20, the discharge It may be performed on the side or in the concentrated water pipe 24.
  • a pump in addition to the reverse osmosis membrane in the system, a pump, a safety filter, a flow rate measuring device, a pressure measuring device, a temperature measuring device, an oxidation-reduction potential (ORP) measuring device, a residual chlorine measuring device, electricity You may equip a conductivity measuring device, a pH measuring device, an energy recovery device, a mineral addition means, etc. as needed.
  • ORP oxidation-reduction potential
  • the pump 14 which is a pressurizing means pressurizes the treated water to be supplied, and has a boosting function for supplying and separating the treated water into the reverse osmosis membrane treatment apparatus 12.
  • the form of this boosting function is not particularly limited.
  • the water to be treated is further pressurized and supplied to the reverse osmosis membrane treatment device 12 in order to perform membrane separation before or after the pump 14 for supplying the water to be treated.
  • a booster pump may be installed separately.
  • a reverse osmosis membrane treatment device may be further installed on the concentrated water side for the purpose of increasing the recovery rate of the entire system.
  • a reverse osmosis membrane treatment device in addition to the reverse osmosis membrane, a pump, a safety filter, a flow rate measurement device, a pressure measurement device, a temperature measurement device, an oxidation-reduction potential (ORP)
  • a measuring device, a residual chlorine measuring device, an electrical conductivity measuring device, a pH measuring device, an energy recovery device, a mineral addition means, and the like may be provided as necessary.
  • the reverse osmosis membrane treatment system 1 for the purpose of improving the quality of the permeate, the reverse osmosis membrane treatment, ion exchange treatment, decarboxylation treatment, electric regeneration type desalting (EDI) treatment, deaeration treatment are further performed on the permeate side.
  • a physical or chemical post-treatment such as a heat exchanger, a membrane separation treatment, an ultraviolet irradiation treatment, or a combination of two or more of these post-treatments may be installed as necessary.
  • a pump in addition to the reverse osmosis membrane in the system, a pump, a safety filter, a flow measuring device, a pressure measuring device, a temperature measuring device, an oxidation-reduction potential (ORP)
  • a measuring device a residual chlorine measuring device, an electrical conductivity measuring device, a pH measuring device, an energy recovery device, a mineral addition means, and the like may be provided as necessary.
  • the above system in which a reverse osmosis membrane treatment apparatus is further installed on the concentrated water side may be combined with the above system in which a reverse osmosis membrane treatment is further installed on the permeate water side.
  • the total chlorine concentration measuring device 16 is connected to the concentrated water circulation pipe 32 as the total chlorine concentration measuring means, but may be connected to the concentrated water pipe 24.
  • the total chlorine concentration measuring device 16 is normally connected to the concentrated water circulation pipe 32 or the concentrated water pipe 24.
  • the primary inlet pressure of the reverse osmosis membrane is 3 MPa or more
  • the pH of the water to be treated is 7 or more
  • the brominated oxidant and the sulfamic acid compound are added to the water to be treated.
  • At least one of a stabilized hypochlorous acid composition containing and a stabilized hypochlorous acid composition containing a chlorinated oxidant and a sulfamic acid compound is present.
  • the “stabilized hypobromite composition containing a bromine-based oxidant and a sulfamic acid compound” is a stabilized hypobromite composition containing a mixture of a “bromine-based oxidant” and a “sulfamic acid compound”. Alternatively, it may be a stabilized hypobromite composition containing a “reaction product of a bromine-based oxidant and a sulfamic acid compound”.
  • the “stabilized hypochlorous acid composition containing a chlorinated oxidant and a sulfamic acid compound” is a stabilized hypochlorous acid composition containing a mixture of a “chlorine oxidant” and a “sulfamic acid compound”. Alternatively, it may be a stabilized hypochlorous acid composition containing a “reaction product of a chlorinated oxidant and a sulfamic acid compound”.
  • the primary inlet pressure of the reverse osmosis membrane is 3 MPa or more
  • the pH of the water to be treated is 7 or more
  • the reverse osmosis membrane treatment method according to the present embodiment has a reverse osmosis membrane primary side inlet pressure of 3 MPa or more, the pH of the water to be treated is 7 or more, and the treatment water contains “bromine oxidant and sulfamine.
  • a stabilized hypochlorous acid composition that is a reaction product with an acid compound or a stabilized hypochlorous acid composition that is a reaction product of a chlorinated oxidant and a sulfamic acid compound is present. is there.
  • the reverse osmosis membrane treatment method according to the present embodiment can be applied to water to be treated, for example, “reaction product of bromine and sulfamic acid compound”, “reaction product of bromine chloride and sulfamic acid compound”, “next Stabilized hypobromite composition "reaction product of bromite and sulfamic acid compound” or "reaction product of sodium bromide and hypochlorous acid and sulfamic acid compound” It is a method to make exist.
  • a stabilized hypochlorous acid composition that is a “reaction product of hypochlorous acid and a sulfamic acid compound” is present in the water to be treated.
  • water to be treated is passed through the reverse osmosis membrane to obtain treated water and concentrated water.
  • the reverse osmosis membrane has slime-inhibiting effect and the amount of permeated water is reduced. Can be suppressed.
  • the treated water is passed through the reverse osmosis membrane to obtain treated water and concentrated water, and has a long-term slime suppression effect of the reverse osmosis membrane, and
  • the stabilized hypobromite composition or the stabilized hypochlorous acid composition has a slime suppression effect equivalent to or higher than that of a chlorine-based oxidizing agent such as hypochlorous acid.
  • a chlorine-based oxidizing agent such as hypochlorous acid.
  • the degradation effect on the reverse osmosis membrane is low compared to chlorine-based oxidizing agents.
  • the stabilized hypobromite composition or the stabilized hypochlorous acid composition used in the reverse osmosis membrane treatment method and treatment system according to this embodiment is a reverse osmosis treatment of treated water with a reverse osmosis membrane. It is suitable as a slime inhibitor used in the membrane treatment method.
  • the pH of the water to be treated supplied to the reverse osmosis membrane device including the reverse osmosis membrane is 7 or more, preferably 7.5 or more, More preferably, it is 8 or more.
  • the pH of the water to be treated is less than 7, the amount of permeated water decreases.
  • the upper limit of the pH of the water to be treated is not particularly limited as long as it is equal to or lower than the upper limit of application of a normal reverse osmosis membrane (for example, pH 12), but considering the scale precipitation of hardness components such as calcium, the pH For example, it is preferable to operate at 9 or less.
  • the reverse osmosis membrane treatment method and the treatment system according to the present embodiment When using the reverse osmosis membrane treatment method and the treatment system according to the present embodiment, by operating at a pH of 7 or higher, the reverse osmosis membrane is deteriorated and the water quality of the treated water (permeated water) is prevented from deteriorating, It is possible to secure a sufficient amount of permeated water while exhibiting a sufficient slime suppressing effect.
  • the treatment water is stabilized so that the total chlorine concentration in the concentrated water, not the treatment water, is in the range of 0.05 mg / L or more and less than 10 mg / L.
  • at least one of a hypobromite composition and a stabilized hypochlorous acid composition is present.
  • the total chlorine concentration in the concentrated water is maintained in a range of 0.1 mg / L or more and less than 5 mg / L, and is maintained in a range of 0.1 mg / L or more and less than 0.5 mg / L. More preferably, it is particularly preferable to maintain it in the range of 0.1 mg / L or more and less than 0.2 mg / L.
  • the total chlorine concentration in the concentrated water is less than 0.05 mg / L, slime cannot be sufficiently suppressed, and if it is 10 mg / L or more, the reverse osmosis membrane may be deteriorated. Even if the total chlorine concentration in the treated water is 0.05 mg / L or more, the total chlorine concentration in the concentrated water of the reverse osmosis membrane is less than 0.05 mg / L depending on the degree of contamination of the treated water and the reverse osmosis membrane. Since slime may not be suppressed, it is not sufficient to control the total chlorine concentration of the water to be treated.
  • bromine-based oxidant or “chlorine-based oxidant” and “sulfamic acid compound” are injected into the water to be treated by a chemical injection pump or the like. May be.
  • the “bromine-based oxidant” or “chlorine-based oxidant” and the “sulfamic acid compound” may be added separately to the water to be treated, or may be mixed with each other and then added to the water to be treated. Good.
  • reaction product of bromine-based oxidant and sulfamic acid compound or “reaction product of chlorine-based oxidant and sulfamic acid compound” may be injected into the water to be treated by a chemical pump or the like. Good.
  • the total chlorine concentration measuring means includes a stabilized hypobromite composition or stabilized hypochlorous acid to be treated or concentrated water to which a stabilized hypobromite composition or stabilized hypochlorous acid composition is added.
  • Any acid composition can be used as long as it can measure the total chlorine concentration.
  • Diethyl-p-phenylenediamine (DPD) colorimetric method diethyl-p-phenylenediamine (DPD)
  • Measuring devices such as absorptiometric method, amperometric method, diethyl-p-phenylenediamine (DPD) titration method, iodine titration method, polarographic method, orthotolidine method and the like.
  • the ratio of the equivalent of the “sulfamic acid compound” to the equivalent of the “bromine-based oxidant” or “chlorine-based oxidant” is preferably 1 or more, A range of 1 or more and 2 or less is more preferable. If the ratio of the equivalent amount of “sulfamic acid compound” to the equivalent amount of “bromine-based oxidant” or “chlorine-based oxidant” is less than 1, there is a possibility of deteriorating the film. There is a case.
  • the total chlorine concentration in contact with the reverse osmosis membrane is preferably 0.01 to 100 mg / L in terms of effective chlorine concentration. If the amount is less than 0.01 mg / L, a sufficient slime-inhibiting effect may not be obtained. If the amount is more than 100 mg / L, the reverse osmosis membrane may be deteriorated and the piping may be corroded.
  • bromine-based oxidizing agents examples include bromine (liquid bromine), bromine chloride, bromic acid, bromate, and hypobromite.
  • Hypobromous acid may be produced by reacting a bromide such as sodium bromide with a chlorine-based oxidizing agent such as hypochlorous acid.
  • the preparation of “bromine and sulfamic acid compound (mixture of bromine and sulfamic acid compound)” or “reaction product of bromine and sulfamic acid compound” using bromine is composed of “hypochlorous acid and bromine compound and Compared to the preparation of “sulfamic acid” and the preparation of “bromine chloride and sulfamic acid”, etc., it is more preferable as a slime inhibitor for a reverse osmosis membrane because it produces less by-product of bromic acid and does not deteriorate the reverse osmosis membrane.
  • the primary inlet pressure of the reverse osmosis membrane is 3 MPa or more, the pH of the water to be treated is 7 or more, and bromine and It is preferable that a sulfamic acid compound is present (a mixture of bromine and a sulfamic acid compound is present). Further, it is preferable that the primary inlet pressure of the reverse osmosis membrane is 3 MPa or more, the pH of the water to be treated is 7 or more, and the reaction product of bromine and a sulfamic acid compound is present in the water to be treated.
  • bromine compounds include sodium bromide, potassium bromide, lithium bromide, ammonium bromide and hydrobromic acid. Of these, sodium bromide is preferable from the viewpoint of formulation cost and the like.
  • Examples of the chlorine-based oxidizing agent include chlorine gas, chlorine dioxide, hypochlorous acid or a salt thereof, chlorous acid or a salt thereof, chloric acid or a salt thereof, perchloric acid or a salt thereof, chlorinated isocyanuric acid or a salt thereof.
  • examples of the salt include alkali metal hypochlorites such as sodium hypochlorite and potassium hypochlorite, alkaline earth hypochlorite such as calcium hypochlorite and barium hypochlorite.
  • alkali metal chlorites such as sodium chlorite and potassium chlorite
  • alkaline earth metal chlorites such as barium chlorite
  • other metal chlorites such as nickel chlorite
  • Alkali metal chlorates such as ammonium chlorate, sodium chlorate and potassium chlorate
  • alkaline earth metal chlorates such as calcium chlorate and barium chlorate.
  • chlorine-based oxidants may be used alone or in combination of two or more.
  • sodium hypochlorite is preferably used from the viewpoint of handleability.
  • the sulfamic acid compound is a compound represented by the following general formula (1).
  • R 2 NSO 3 H (1) (In the formula, R is independently a hydrogen atom or an alkyl group having 1 to 8 carbon atoms.)
  • sulfamic acid compound examples include sulfamic acid (amidosulfuric acid) in which both two R groups are hydrogen atoms, N-methylsulfamic acid, N-ethylsulfamic acid, N-propylsulfamic acid, N- A sulfamic acid compound in which one of two R groups such as isopropylsulfamic acid and N-butylsulfamic acid is a hydrogen atom and the other is an alkyl group having 1 to 8 carbon atoms, N, N-dimethylsulfamic acid, N, Two R groups such as N-diethylsulfamic acid, N, N-dipropylsulfamic acid, N, N-dibutylsulfamic acid, N-methyl-N-ethylsulfamic acid, N-methyl-N-propylsulfamic acid, etc.
  • sulfamic acid amidosulfuric
  • One of two R groups such as a sulfamic acid compound, N-phenylsulfamic acid and the like, both of which are alkyl groups having 1 to 8 carbon atoms Is a hydrogen atom and the other sulfamic acid compound or a salt thereof, such as an aryl group having 6 to 10 carbon atoms.
  • the sulfamate include alkali metal salts such as sodium salt and potassium salt, alkaline earth metal salts such as calcium salt, strontium salt and barium salt, manganese salt, copper salt, zinc salt, iron salt, cobalt salt, Other metal salts such as nickel salts, ammonium salts, guanidine salts and the like can be mentioned.
  • the sulfamic acid compounds and salts thereof may be used alone or in combination of two or more.
  • sulfamic acid compound sulfamic acid (amidosulfuric acid) is preferably used from the viewpoint of environmental load.
  • an alkali may be further present.
  • the alkali include alkali hydroxides such as sodium hydroxide and potassium hydroxide. From the viewpoint of product stability at low temperatures, sodium hydroxide and potassium hydroxide may be used in combination. Further, the alkali is not solid and may be used as an aqueous solution.
  • acids such as hydrochloric acid and sulfuric acid and alkalis such as sodium hydroxide can be used.
  • the reverse osmosis membrane used in the reverse osmosis membrane treatment method and treatment system according to the present embodiment may be a reverse osmosis membrane that can be operated at a primary inlet pressure of 3 MPa or more.
  • the reverse osmosis membrane treatment method and treatment system according to this embodiment can be suitably applied to cellulose acetate and polyamide polymer membranes that are currently mainstream.
  • Polyamide polymer membranes have a relatively low resistance to oxidizing agents, and when free chlorine or the like is continuously brought into contact with the polyamide polymer membrane, the membrane performance is significantly reduced.
  • such a remarkable membrane performance degradation hardly occurs even in the polyamide polymer membrane.
  • the reverse osmosis membrane examples include a high pressure membrane, a medium pressure membrane, a low pressure membrane, and an ultra-low pressure membrane, and a reverse osmosis membrane preferably having a maximum working pressure of greater than 4.16 MPa.
  • the “maximum operating pressure” is a maximum pressure on the primary side that can be continuously used without damaging the structure or performance of the module and element described in JIS K3802: 2015 “Membrane terminology”.
  • a primary side inlet pressure of 5.5 MPa, an effective pressure of 2.7 MPa, an NaCl concentration of 32000 mg / L, and a permeation flux at a temperature of 25 ° C. are generally referred to as a high pressure membrane.
  • a high pressure membrane 1 to 3.0 m 3 / m 2 / day, preferably 0.3 to 2.0 m 3 / m 2 / day, more preferably 0.5 to 1.7 m 3 / m 2 / day
  • the “effective pressure (effective pressure)” is an effective pressure acting on the membrane obtained by subtracting the osmotic pressure difference and the secondary side pressure from the average operating pressure described in JIS K3802: 2015 “Membrane terms”.
  • the membrane shape of the reverse osmosis membrane is not particularly limited, and examples thereof include an annular type, a flat membrane type, a spiral type, a hollow fiber type, and the like, such as a 4-inch type, an 8-inch type, and a 16-inch type. Either may be used.
  • the primary inlet pressure of the water to be treated supplied to the reverse osmosis membrane device including the reverse osmosis membrane is 3 MPa or more, but 4 MPa or more. Preferably, it is 5 MPa or more.
  • the upper limit of the primary side inlet pressure of the reverse osmosis membrane is not particularly limited, and may be not more than the maximum working pressure (for example, 8.3 MPa) of the reverse osmosis membrane.
  • the effective pressure of the water to be treated supplied to the reverse osmosis membrane device including the reverse osmosis membrane is preferably 0.8 MPa or more, and 1.0 MPa or more. It is more preferable that
  • a dispersant is used in combination with the stabilized hypochlorous acid composition or the stabilized hypochlorous acid composition to suppress the scale. Also good.
  • the dispersant include polyacrylic acid, polymaleic acid, and phosphonic acid.
  • the amount of the dispersant added to the water to be treated is, for example, in the range of 0.1 to 1,000 mg / L as the concentration in the RO concentrated water.
  • chlorine is present on the surface (skin layer) of the reverse osmosis membrane.
  • “Chlorine is present on the surface of the reverse osmosis membrane” means that chlorine is detected in the X-ray photoelectron spectroscopy (XPS) analysis of the surface of the dried reverse osmosis membrane, that is, the detection lower limit value or more.
  • the chlorine concentration on the surface of the reverse osmosis membrane by XPS analysis may be not less than the lower limit of detection, but is preferably 0.2 atomic% or more, more preferably 0.4 atomic% or more, and 0.46 atomic%. More preferably, it is the above.
  • the upper limit of the chlorine concentration on the surface of the reverse osmosis membrane is not particularly specified, but is preferably 10 atomic% or less, for example.
  • reverse osmosis membrane device examples include pure water production, seawater desalination, and wastewater collection.
  • the reverse osmosis membrane treatment method and treatment system according to the present embodiment can be suitably applied to seawater desalination and wastewater recovery that are particularly operated at high pressure.
  • Examples of water to be treated include brine water (seawater or brackish water), drainage, fresh water, industrial water, city water, well water, pure water, ultrapure water, etc., and the reverse osmosis membrane treatment method and treatment system according to this embodiment are In particular, the effect of irrigation was confirmed.
  • the “brine water” here is 0.05 to 5% by weight of water in salt concentration.
  • Examples of the salt contained in the brine include sodium chloride, magnesium chloride, magnesium sulfate, calcium sulfate, and potassium chloride.
  • the conductivity of brine is in the range of 600-80000 ⁇ S / cm.
  • the water to be treated is preferably pretreated water that has been previously treated in the pretreatment.
  • the water treatment system 5 includes the reverse osmosis membrane treatment system 1 or 3, and includes a pretreatment system 50 in front of the reverse osmosis membrane treatment system 1 or 3.
  • the raw water supply pipe 52 is connected to the inlet of the pretreatment system 50, and the outlet of the pretreatment system 50 and the inlet of the reverse osmosis membrane treatment system 1 or 3 are connected by the pretreatment water supply pipe 54.
  • the pretreated water supply pipe 54 is connected to the treated water pipe 18 of the reverse osmosis membrane treatment system 1 or 3.
  • the addition pipe 26 for adding at least one of the stabilized hypochlorous acid composition and the stabilized hypochlorous acid composition includes the raw water supply pipe 52 as the addition pipe 26a and the pretreatment system 50 as the addition pipe 26b.
  • the pretreatment water supply pipe 54 is connected as the addition pipe 26c and the reverse osmosis membrane treatment system 1 or 3 is connected as the addition pipe 26d.
  • the raw water is supplied to the pretreatment system 50 through the raw water supply pipe 52, and the pretreatment described later is performed in the pretreatment system 50 (pretreatment step).
  • the pretreated water subjected to the pretreatment is supplied to the reverse osmosis membrane treatment system 1 or 3 through the pretreated water supply pipe 54.
  • the reverse osmosis membrane treatment is performed as described above (reverse osmosis membrane treatment step).
  • At least one of the stabilized hypochlorous acid composition and the stabilized hypochlorous acid composition is supplied to the raw water supply pipe 52 through the addition pipe 26a, the pretreatment system 50 through the addition pipe 26b, and the pretreatment water supply through the addition pipe 26c.
  • the reverse osmosis membrane treatment system 1 or 3 through the pipe 54 and the addition pipe 26d, it may be added to at least one of raw water, pretreated water, and water to be treated.
  • pretreatment process biological treatment, flocculation treatment, flocculation precipitation treatment, pressurized flotation treatment, filtration treatment, membrane separation treatment, activated carbon treatment, decarboxylation treatment, softening treatment, ozone treatment, ultraviolet irradiation treatment, etc. Physical or chemical pretreatments and combinations of two or more of these pretreatments are performed as needed.
  • a pump in addition to the reverse osmosis membrane in the system, a pump, a safety filter, a flow rate measuring device, a pressure measuring device, a temperature measuring device, an oxidation-reduction potential (ORP) measuring device, and a residual chlorine measuring device
  • a pump in addition to the reverse osmosis membrane in the system, a pump, a safety filter, a flow rate measuring device, a pressure measuring device, a temperature measuring device, an oxidation-reduction potential (ORP) measuring device, and a residual chlorine measuring device
  • ORP oxidation-reduction potential
  • an electrical conductivity measuring device a pH measuring device, an energy recovery device, a mineral adding means, and the like may be provided as necessary.
  • a scale inhibitor other than the stabilized hypobromite composition or the stabilized hypochlorous acid composition, and a pH adjuster are added to the raw water supply pipe 52, the pretreatment system 50, In at least one of the pretreatment water supply pipe 54 and the reverse osmosis membrane treatment system 1 or 3, it may be added to at least one of raw water, pretreatment water, and water to be treated.
  • the slime inhibitor for reverse osmosis membrane is a stabilized hypobromite composition or stabilized hypochlorous acid containing a mixture of “bromine-based oxidant or chlorine-based oxidant” and “sulfamic acid compound”. It contains an acid composition and may further contain an alkali.
  • the slime inhibitor for reverse osmosis membrane is a stabilized hypobromite composition containing “a reaction product of a bromine-based oxidant and a sulfamic acid compound”, or “a chlorine-based oxidant and a sulfamine”. It contains a stabilized hypochlorous acid composition including a “reaction product with an acid compound”, and may further contain an alkali.
  • the bromine-based oxidizing agent, bromine compound, chlorine-based oxidizing agent, and sulfamic acid compound are as described above.
  • Examples of commercially available stabilized hypochlorous acid compositions containing a chlorine-based oxidizing agent and a sulfamic acid compound include “Kuriverter IK-110” manufactured by Kurita Kogyo Co., Ltd.
  • one containing bromine and a sulfamic acid compound (containing a mixture of bromine and a sulfamic acid compound), for example, in order not to further deteriorate the reverse osmosis membrane
  • a mixture of bromine, sulfamic acid compound, alkali and water, or a reaction product of bromine and sulfamic acid compound for example, reaction product of bromine and sulfamic acid compound, alkali, water and Is preferred.
  • a slime inhibitor containing a stabilized hypobromite composition containing a bromine-based oxidant and a sulfamic acid compound, particularly containing bromine and a sulfamic acid compound.
  • the slime inhibitor containing the stabilized hypobromite composition has higher oxidizing power than the slime inhibitor (chlorosulfamic acid, etc.) containing a chlorinated oxidant and a sulfamic acid compound.
  • chlorosulfamic acid, etc. containing a chlorinated oxidant and a sulfamic acid compound.
  • the slime inhibitor for reverse osmosis membrane according to the present embodiment hardly permeates the reverse osmosis membrane, and therefore has little influence on the quality of treated water. Further, since the concentration can be measured on site in the same manner as hypochlorous acid or the like, more accurate concentration management is possible.
  • the pH of the slime inhibitor for reverse osmosis membrane is, for example, more than 13.0, and more preferably more than 13.2.
  • the pH of the slime inhibitor for reverse osmosis membrane is 13.0 or less, the effective halogen in the slime inhibitor for reverse osmosis membrane may become unstable.
  • the bromic acid concentration in the reverse osmosis membrane slime inhibitor is preferably less than 5 mg / kg.
  • concentration of bromate ions in the RO permeate may increase.
  • the slime inhibitor for reverse osmosis membrane according to this embodiment is obtained by mixing a bromine-based oxidant or a chlorine-based oxidant and a sulfamic acid compound, and may further mix alkali.
  • bromine is an inert gas in a mixed liquid containing water, an alkali and a sulfamic acid compound. It is preferable to include a step of adding and reacting under an atmosphere or a step of adding bromine to a mixed solution containing water, an alkali and a sulfamic acid compound under an inert gas atmosphere.
  • the bromate ion concentration in the slime inhibitor for reverse osmosis membranes is lowered, and the bromate ion concentration in RO permeated water becomes lower.
  • the inert gas to be used is not limited, at least one of nitrogen and argon is preferable from the viewpoint of manufacturing and the like, and nitrogen is particularly preferable from the viewpoint of manufacturing cost and the like.
  • the oxygen concentration in the reactor during the addition of bromine is preferably 6% or less, more preferably 4% or less, further preferably 2% or less, and particularly preferably 1% or less. If the oxygen concentration in the reactor during the bromine reaction exceeds 6%, the amount of bromic acid produced in the reaction system may increase.
  • the addition rate of bromine is preferably 25% by weight or less, more preferably 1% by weight or more and 20% by weight or less based on the total amount of the slime inhibitor for reverse osmosis membranes. If the bromine addition rate exceeds 25% by weight with respect to the total amount of the slime inhibitor for reverse osmosis membranes, the amount of bromic acid produced in the reaction system may increase. If it is less than 1% by weight, the sterilizing power may be inferior.
  • the reaction temperature at the time of bromine addition is preferably controlled in the range of 0 ° C. to 25 ° C., but more preferably in the range of 0 ° C. to 15 ° C. from the viewpoint of production cost.
  • the reaction temperature at the time of bromine addition exceeds 25 degreeC, the production amount of the bromic acid in a reaction system may increase, and when it is less than 0 degreeC, it may freeze.
  • composition 1 Preparation of Stabilized Hypobromite Composition (Composition 1)] Under nitrogen atmosphere, liquid bromine: 16.9% by weight (wt%), sulfamic acid: 10.7% by weight, sodium hydroxide: 12.9% by weight, potassium hydroxide: 3.94% by weight, water: remaining The components were mixed to prepare a stabilized hypobromite composition (Composition 1).
  • the stabilized hypobromite composition had a pH of 14 and a total chlorine concentration of 7.5% by weight.
  • the detailed method for preparing the stabilized hypobromite composition is as follows.
  • Composition 1 was obtained.
  • the pH of the resulting solution was 14 as measured by the glass electrode method.
  • the bromine content of the resulting solution was 16.9% as measured by a redox titration method using sodium thiosulfate after bromine was converted to iodine with potassium iodide, and the theoretical content (16.9% ) Of 100.0%.
  • the oxygen concentration in the reaction vessel during the bromine reaction was measured using “Oxygen Monitor JKO-02 LJDII” manufactured by Zico Corporation.
  • the bromic acid concentration was less than 5 mg / kg.
  • Electrode type Glass electrode type pH meter: IOL-30, manufactured by Toa DKK Corporation
  • Electrode calibration Neutral phosphate pH (6.86) standard solution (type 2) manufactured by Kanto Chemical Co., boric acid manufactured by the same company Salt temperature (9.18) Standard solution (type 2) was measured by two-point calibration
  • Measurement value Immerse the electrode in the measurement solution and use the value after stabilization as the measurement value.
  • composition 2 12% sodium hypochlorite aqueous solution: 50% by weight, sulfamic acid: 12% by weight, sodium hydroxide: 8% by weight, water: the remainder is mixed to stabilize a hypochlorous acid composition (Composition 2) was prepared.
  • Composition 2 had a pH of 13.7 and a total chlorine concentration of 6.2% by weight.
  • Examples 1 to 3 [Comparison test of bactericidal activity]
  • water was passed under the following test conditions using the element test apparatus shown in FIG. The chemical was stabilized by using hypochlorous acid composition (Composition 1) and adjusted to pH 8.0, 7.5, 7.0 at a primary inlet pressure of 3 MPa on the reverse osmosis membrane, respectively. did.
  • Test equipment Element test equipment
  • Reverse osmosis membrane SWC5 (manufactured by Nitto Denko, polyamide polymer membrane)
  • Membrane type high pressure membrane (primary side inlet pressure 5.5 MPa, effective pressure 2.7 MPa, NaCl concentration 32000 mg / L, permeation flux at a temperature of 25 ° C.
  • Example 1 In Example 1, the permeate retention rate was 100%, in Example 2, the permeate retention rate was 93%, and in Example 3, the permeate retention rate was 81%.
  • Table 1 The results are shown in Table 1 and FIG.
  • the permeated water retention rate was 80% or more at pH 8.0, 7.5, and 7.0, and the decrease in the permeated water amount was suppressed.
  • Comparative Example 1 Water was passed under the above test conditions using the element test apparatus shown in FIG.
  • medical agent used the stabilized hypobromite composition (composition 1), adjusted pH to 6.5 with the primary side inlet pressure of 3 MPa of a reverse osmosis membrane, and let water flow.
  • Example 4 water was passed under the following test conditions using the element test apparatus shown in FIG.
  • medical agent used the stabilized hypochlorous acid composition (composition 2), adjusted pH to 7.5 with the primary side inlet pressure of 3 MPa of a reverse osmosis membrane, and let water flow.
  • Test equipment Element test equipment
  • Reverse osmosis membrane TM800C (manufactured by Toray, polyamide polymer membrane)
  • Membrane type high pressure membrane (primary side inlet pressure 5.5 MPa, effective pressure 2.7 MPa, NaCl concentration 32000 mg / L, permeation flux at a temperature of 25 ° C.
  • Example 4 In Example 4, the permeated water retention rate was 95%. The results are shown in Table 1 and FIG. Thus, at the primary inlet pressure of 3 MPa for the reverse osmosis membrane, the permeated water retention rate was 80% or more at pH 7.5, and the decrease in the permeated water amount was suppressed.
  • Examples 5 to 7 [Reverse osmosis membrane comparison test]
  • water was passed under the following test conditions.
  • medical agent used the stabilized hypobromite composition (composition 1), adjusted pH to 8.5 each with the primary side inlet pressure of 3 MPa of a reverse osmosis membrane, and let water flow.
  • Test apparatus Element test apparatus Reverse osmosis membrane: Nitto Denko polyamide polymer membrane (Example 5), Toray polyamide polymer membrane (Example 6), DOW polyamide polymer membrane (Example 7) ) ⁇ Membrane type: high pressure membrane (primary side inlet pressure 5.5 MPa, effective pressure 2.7 MPa, NaCl concentration 32000 mg / L, permeation flux at a temperature of 25 ° C. is 0.9 m 3 / m 2 / day (Nitto Denko polyamide system) Polymer membrane), the permeation flux at a temperature of 25 ° C.
  • Example 5 The results are shown in Table 2. In Example 5, the permeated water retention rate was 98%, in Example 6, the permeated water retention rate was 94%, and in Example 7, the permeated water retention rate was 83%.
  • Table 2 shows the chlorine concentration on the surface of the reverse osmosis membrane (polyamide polymer membrane) before passing water.
  • Example 5 As for Nitto Denko's polyamide polymer membrane (Example 5) and Toray's polyamide polymer membrane (Example 6), it was found that chlorine was detected on the surface of the polyamide polymer membrane before water passage. It was. On the other hand, about the polyamide-type polymer membrane (Example 7) made from DOW, it turned out that the chlorine of the surface of the polyamide-type polymer membrane before water flow is less than a detection lower limit. From this, it is considered that the chlorine on the surface of the reverse osmosis membrane (polyamide polymer membrane) has an effect on the suppression of the decrease in the permeate retention rate of the reverse osmosis membrane.
  • Example 8 to 10 [Reverse osmosis membrane comparison test]
  • water was passed under the following test conditions using the element test apparatus shown in FIG.
  • medical agent used the stabilized hypobromite composition (composition 1), adjusted pH to 8.0 each at the primary side inlet pressure of 3 MPa of a reverse osmosis membrane, and let water flow.
  • Test device Element test device Reverse osmosis membrane: SWC4 + (Nitto Denko polyamide polymer membrane: Example 8), SWC5 (Nitto Denko polyamide polymer membrane: Example 9), SWC6 (Nitto Denko polyamide) -Based polymer membrane: Example 10)
  • Membrane type high pressure membrane (SWC4 +: primary inlet pressure 5.5 MPa, effective pressure 2.7 MPa, NaCl concentration 32000 mg / L, permeation flux at a temperature of 25 ° C.
  • Example 8 The results are shown in Table 3.
  • Example 9 the permeate retention rate was 93%, in Example 9, the permeate retention rate was 99%, and in Example 10, the permeate retention rate was 89%.
  • Example 10 a decrease in the amount of permeated water was observed as compared with Example 8 and Example 9.
  • a polyamide polymer membrane was cut into the size of a sample holder (about 4 mm ⁇ 5 mm) of a flat plate zeta potential measurement cell, and the sample was adhered to the holder so that the measurement surface faced up was used as a measurement sample.
  • a polymer latex particle polystyrene 100 nm diameter standard solution Nanophene Size Standard
  • dispersed in 0.01 mol / L sodium chloride solution is used as a tracer suspension, and the pH is adjusted to 8 using sodium hydroxide aqueous solution and hydrochloric acid. It was adjusted.
  • the flat plate zeta potential measurement cell on which the sample holder was set was immersed in the tracer suspension and measured at 25 ° C.
  • the tracer suspension pH at this time was measured.
  • the refractive index, dielectric constant, and viscosity of the solvent were set to water values. In order to confirm reproducibility, repeated measurements were performed.
  • Measuring apparatus Zetasizer Nano ZS (electrophoresis method) manufactured by Malvern Flat plate zeta potential measurement cell (ZEN1020)
  • Table 3 shows the zeta potential on the surface of the polyamide polymer membrane before passing water.
  • the reverse osmosis membrane treatment at a high pressure by passing the treated water through the reverse osmosis membrane to obtain the treated water and the concentrated water by the method of the embodiment, it has a slime suppression effect of the reverse osmosis membrane, And the fall of the permeated water amount was able to be suppressed.
  • 1,3 reverse osmosis membrane treatment system 5 water treatment system, 10 treated water tank, 12 reverse osmosis membrane treatment device, 14 pump, 16 total chlorine concentration measuring device, 18 treated water piping, 20 treated water supply piping, 22 Permeated water piping, 24 concentrated water piping, 26, 26a, 26b, 26c, 26d, 26e, 26f additional piping, 28 pH adjuster added piping, 30 pH measuring device, 32 concentrated water circulation piping, 50 pretreatment system, 52 raw water supply Piping, 54 Pretreatment water supply piping.

Landscapes

  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hydrology & Water Resources (AREA)
  • Environmental & Geological Engineering (AREA)
  • Organic Chemistry (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)

Abstract

L'objectif de la présente invention est de fournir un procédé de traitement par membrane d'osmose inverse et un système de traitement par membrane d'osmose inverse qui ont un effet de suppression de boue pour la membrane d'osmose inverse et suppriment les réductions de quantité de perméation d'eau dans un traitement par membrane d'osmose inverse à haute pression, l'eau à traiter traversant une membrane d'osmose inverse pour obtenir de l'eau traitée et de l'eau concentrée. L'invention concerne un procédé de traitement par membrane d'osmose inverse et un système de traitement par membrane d'osmose inverse permettant de faire passer l'eau à traiter à travers la membrane d'osmose inverse et d'obtenir de l'eau traitée et de l'eau concentrée, la pression d'entrée primaire pour la membrane d'osmose inverse dans un dispositif de traitement par membrane d'osmose inverse (12) étant de 3 MPa ou plus, le pH de l'eau à traiter étant supérieur ou égal à 7, et une composition d'acide hypobromeux stabilisée et/ou une composition d'acide hypochloreux stabilisée étant présente dans l'eau à traiter.
PCT/JP2017/038675 2016-11-07 2017-10-26 Procédé de traitement par membrane d'osmose inverse et système de traitement par membrane d'osmose inverse Ceased WO2018084061A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201780067825.7A CN109890764A (zh) 2016-11-07 2017-10-26 反渗透膜处理方法及反渗透膜处理系统
JP2018548965A JP6622424B2 (ja) 2016-11-07 2017-10-26 逆浸透膜処理方法および逆浸透膜処理システム

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016-216892 2016-11-07
JP2016216892 2016-11-07

Publications (1)

Publication Number Publication Date
WO2018084061A1 true WO2018084061A1 (fr) 2018-05-11

Family

ID=62076060

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/038675 Ceased WO2018084061A1 (fr) 2016-11-07 2017-10-26 Procédé de traitement par membrane d'osmose inverse et système de traitement par membrane d'osmose inverse

Country Status (3)

Country Link
JP (1) JP6622424B2 (fr)
CN (1) CN109890764A (fr)
WO (1) WO2018084061A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110569604A (zh) * 2019-09-11 2019-12-13 江西省科学院能源研究所 一种模拟有机物致反渗透膜污染的耗散粒子动力学方法
JP2020040008A (ja) * 2018-09-07 2020-03-19 三浦工業株式会社 水処理システム
JP2020081939A (ja) * 2018-11-20 2020-06-04 三浦工業株式会社 水処理システム
CN112601717A (zh) * 2018-08-23 2021-04-02 栗田工业株式会社 反渗透膜装置的黏泥抑制方法
CN113507981A (zh) * 2019-03-07 2021-10-15 奥加诺株式会社 使用反渗透膜的水处理方法和水处理装置

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230174399A1 (en) * 2020-03-24 2023-06-08 Organo Corporation Water treatment method, water treatment device and slime inhibitor for membranes
WO2021192583A1 (fr) * 2020-03-24 2021-09-30 オルガノ株式会社 Système et procédé de récupération d'eau
WO2022186013A1 (fr) * 2021-03-05 2022-09-09 オルガノ株式会社 Procédé de traitement de l'eau et composition d'agent de traitement de l'eau

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1066845A (ja) * 1996-08-26 1998-03-10 Nitto Denko Corp 逆浸透複合膜
JP2010227836A (ja) * 2009-03-27 2010-10-14 Toray Ind Inc 膜モジュールの運転方法
WO2013005787A1 (fr) * 2011-07-06 2013-01-10 栗田工業株式会社 Procédé de séparation sur membrane
WO2015029504A1 (fr) * 2013-08-28 2015-03-05 オルガノ株式会社 Procédé de production de composition d'acide hypobromeux stabilisée, composition d'acide hypobromeux stabilisée, et procédés d'inhibition de biofilm pour membrane de séparation
JP2016120466A (ja) * 2014-12-25 2016-07-07 オルガノ株式会社 ろ過処理システムおよびろ過処理方法
WO2016136304A1 (fr) * 2015-02-24 2016-09-01 オルガノ株式会社 Procédé pour la modification de membrane d'osmose inverse, membrane d'osmose inverse, procédé de traitement pour de l'eau contenant du bore et procédé pour la mise en œuvre d'une membrane d'osmose inverse
WO2016158633A1 (fr) * 2015-03-31 2016-10-06 栗田工業株式会社 Procédé de fonctionnement de système de traitement sur membrane d'osmose inverse et système de traitement sur membrane d'osmose inverse

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000288356A (ja) * 1999-02-02 2000-10-17 Toray Ind Inc 逆浸透膜分離装置および造水方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1066845A (ja) * 1996-08-26 1998-03-10 Nitto Denko Corp 逆浸透複合膜
JP2010227836A (ja) * 2009-03-27 2010-10-14 Toray Ind Inc 膜モジュールの運転方法
WO2013005787A1 (fr) * 2011-07-06 2013-01-10 栗田工業株式会社 Procédé de séparation sur membrane
WO2015029504A1 (fr) * 2013-08-28 2015-03-05 オルガノ株式会社 Procédé de production de composition d'acide hypobromeux stabilisée, composition d'acide hypobromeux stabilisée, et procédés d'inhibition de biofilm pour membrane de séparation
JP2016120466A (ja) * 2014-12-25 2016-07-07 オルガノ株式会社 ろ過処理システムおよびろ過処理方法
WO2016136304A1 (fr) * 2015-02-24 2016-09-01 オルガノ株式会社 Procédé pour la modification de membrane d'osmose inverse, membrane d'osmose inverse, procédé de traitement pour de l'eau contenant du bore et procédé pour la mise en œuvre d'une membrane d'osmose inverse
WO2016158633A1 (fr) * 2015-03-31 2016-10-06 栗田工業株式会社 Procédé de fonctionnement de système de traitement sur membrane d'osmose inverse et système de traitement sur membrane d'osmose inverse

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112601717A (zh) * 2018-08-23 2021-04-02 栗田工业株式会社 反渗透膜装置的黏泥抑制方法
US12083480B2 (en) 2018-08-23 2024-09-10 Kurita Water Industries Ltd. Method for controlling slime in reverse osmosis membrane apparatus
JP2020040008A (ja) * 2018-09-07 2020-03-19 三浦工業株式会社 水処理システム
JP2020081939A (ja) * 2018-11-20 2020-06-04 三浦工業株式会社 水処理システム
JP7180310B2 (ja) 2018-11-20 2022-11-30 三浦工業株式会社 水処理システム
CN113507981A (zh) * 2019-03-07 2021-10-15 奥加诺株式会社 使用反渗透膜的水处理方法和水处理装置
CN110569604A (zh) * 2019-09-11 2019-12-13 江西省科学院能源研究所 一种模拟有机物致反渗透膜污染的耗散粒子动力学方法
CN110569604B (zh) * 2019-09-11 2023-04-07 江西省科学院能源研究所 一种模拟有机物致反渗透膜污染的耗散粒子动力学方法

Also Published As

Publication number Publication date
JPWO2018084061A1 (ja) 2019-04-11
CN109890764A (zh) 2019-06-14
JP6622424B2 (ja) 2019-12-18

Similar Documents

Publication Publication Date Title
JP6622424B2 (ja) 逆浸透膜処理方法および逆浸透膜処理システム
JP6807219B2 (ja) 逆浸透膜処理システムおよび逆浸透膜処理方法
WO2015170495A1 (fr) Système de traitement de filtration et procédé de traitement de filtration
JP6970516B2 (ja) 逆浸透膜を用いる水処理方法
JP6688381B2 (ja) 逆浸透膜を用いた水処理システムおよび水処理方法
JP2016120466A (ja) ろ過処理システムおよびろ過処理方法
KR102291224B1 (ko) 역침투막을 이용하는 수처리 방법 및 수처리 장치
KR102675437B1 (ko) 역침투막을 이용하는 수처리 방법 및 수처리 장치
JP7013141B2 (ja) 逆浸透膜を用いる水処理方法
JP6837301B2 (ja) 逆浸透膜処理方法および逆浸透膜処理システム
JP2016155071A (ja) 分離膜の殺菌方法
JP7008470B2 (ja) 逆浸透膜処理方法および逆浸透膜処理システム
JP2018008182A (ja) 逆浸透膜を用いる水処理方法、および逆浸透膜におけるシリカの阻止率向上剤
JP6974936B2 (ja) 逆浸透膜を用いる水処理方法
JP6823401B2 (ja) 低分子有機物含有水の処理方法および逆浸透膜の改質方法
JP6682401B2 (ja) 逆浸透膜を用いる水処理方法
JP2016155067A (ja) 逆浸透膜の改質方法、逆浸透膜、およびホウ素含有水の処理方法
JP2018069124A (ja) 逆浸透膜を用いる水処理装置および水処理方法
WO2018037582A1 (fr) Procédé de traitement d'eau utilisant une membrane d'osmose inverse
JP2018030074A (ja) ポリアミド系逆浸透膜、およびそのポリアミド系逆浸透膜の製造方法
WO2018142904A1 (fr) Procédé de modification de membrane d'osmose inverse, membrane d'osmose inverse, procédé de traitement d'eau contenant une substance non chargée, procédé de fonctionnement pour membrane d'osmose inverse et dispositif de membrane d'osmose inverse
JP6457807B2 (ja) 水処理装置および水処理方法
JP7141919B2 (ja) 逆浸透膜処理方法、逆浸透膜処理システム、水処理方法、および水処理システム
JP6933902B2 (ja) 逆浸透膜の改質方法、および、非荷電物質含有水の処理方法
JP7144922B2 (ja) 逆浸透膜の運転方法および逆浸透膜装置

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17868205

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2018548965

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17868205

Country of ref document: EP

Kind code of ref document: A1